Medical Cannabis Research Australia | Medical research centre

Medical Cannabis Research Australia

Phone: +6193880810

Add/Update information

Reviews

Tags

• Businesses
• Medical and health
• Non-profit organisation
• Educational research centre
• Medical research centre

25.01.2022 RESEARCH SHARE Cannabidiol (CBD) as a treatment of acute and chronic back pain: A case series and literature review. May/Jun 2020 PubMed Conclusion: Hemp-derived CBD in a transdermal cream provided significant symptom and pain relief for the patients described in this case series. Based on these results, we believe further investigation is warranted to see if CBD-containing products should have a more prominent role in the treatment of acute and chronic pain.... https://pubmed.ncbi.nlm.nih.gov/32421842/ https://wmpllc.org/ojs/index.php/jom/article/view/2748

25.01.2022 I love that the UK have a Medical Cannabis Awareness Week, coming up on 1-8 November! I applaud PLEA - Patient-Led Engagement for Access for their initiative and I hope that Australia could have something similar. MedCan Support https://docs.google.com//1FAIpQLSd06mzCsVt1d_95n/viewform

25.01.2022 QUESTION The endocannabinoid system has been described as a system composed of neurotransmitters and receptors. The receptors are found throughout the central nervous system and peripheral nervous system. Are receptors also found on non-nerve cells? ANSWER Yes. CB2 receptors are found throughout the immune system. They are present on B cells, T cells, and macrophages. Also, CB2 receptors are expressed on cells of the spleen, liver, kidneys and skin.

25.01.2022 We have 400 registered to watch on Thursday night! 4 DAYS TO GO! It's going to be a 'must-see' event! Don't miss out! Get your FREE registration here https://us02web.zoom.us//register/WN_9B_aNQnARxObFO2SV-_3QQ... Medical Cannabis and You - A Patient Webinar Join a panel of industry experts to answer patient questions. This webinar will cover everything from patient personal experience, conditions & evidence, dosage forms & interactions, manufacture to current Aussie clinical trials. THE PRESENTERS: * Lesley Shaw Adenan Prescribed Patient: Personal experience with MC for cancer symptoms, neuropathy, arthritis, sleep & more * Dr Jamie Rickcord, Ananda clinics Medical Director & GP prescriber: Conditions & Evidence * Paul Mavor, Health House Pharma, Pharmacist: Dosage forms, formulations, etc. * Barb Fullerton, Little Green Pharma, National Education Manager: Australian MC Overview, Cultivation, manufacture - seed to sale * Kat, mum of Prescribed Patient : Personal experience with MC for her Autism SD son * Sharlene Mavor, Medical Cannabis Research Australia , Medical Scientist: Current Aussie clinical trials Date: Thursday 5th NOVEMBER 2020 at 7:00pm AEST Duration: ~1 hour, 15mins (depending on Q&A) Venue: The comfort of your own home (it's a webinar) Cost: Free. Register now at https://us02web.zoom.us//register/WN_9B_aNQnARxObFO2SV-_3QQ

25.01.2022 Clinical Study Share : 'Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly' 2018 March Conclusion: Our study finds that the therapeutic use of cannabis is safe and efficacious in the elderly population. Cannabis use may decrease the use of other prescription medicines, including opioids. Gathering more evidence-based data, including data from double-blind randomized-controlled trials, in this special population is imperative. https://pubmed.ncbi.nlm.nih.gov/29398248/

24.01.2022 FREE PATIENT EDUCATION WEBINAR - Register now! Join a panel of industry experts to answer patient questions. This webinar will cover everything from patient per...sonal experience, conditions & evidence, dosage forms & interactions, manufacture to current Aussie clinical trials. Date: Thursday 5th NOVEMBER 7:00pm (Eastern States time) 4:00pm (WA time) Duration: ~1 hour (depending on Q&A) Venue: the comfort of your own home (it's a webinar) Cost: Free Register now at https://us02web.zoom.us//register/WN_9B_aNQnARxObFO2SV-_3QQ Ananda clinics Little Green Pharma Paul Ronald Mavor #mcraorgau #mcraevent #mcraeducation #mcraseminar #mcraadvocate #medicalcannabis #medicinalcannabis #cannabiseducation #littlegreenpharma #anandaclinics #healthhouseinternational

24.01.2022 An excellent article by industry expert Rhys Cohen of CannaBiz : Analysis: Thousands of Australians are forced to break the cannabis laws. It doesn’t have to be this way.

23.01.2022 QUESTION In 2020, the 20 member ‘Global Task Force on Dosing and Administration of Medical Cannabis in Chronic Pain’ developed recommendations for the dosing of cannabinoids. These recommendations were presented at a virtual PAINWeek meeting. One of their recommendations included Treat the majority of patients along the routine scale. What does this mean? ANSWER Treating the majority of patients along the routine scale means to start with a dose of 5 mg of cannabidiol ...(CBD) twice daily, and tetrahydrocannabinol (THC) should only be added if the patient does not respond to at least 40 mg of CBD daily. If THC is added, the starting dose should be 2.5-mg daily. THC doses should be capped at 40 mg daily. Reference here :https://www.healio.com//global-task-force-establishes-prot

23.01.2022 QUESTION What physiological systems are affected by the endocannabinoid system? ANSWER In addition to regulating neuronal excitability and inflammation in pain circuits, the endocannabinoid system has been shown to play a regulatory role in movement, appetite, hypothalamic-pituitary-adrenal axis modulation, immunomodulation, mood, blood pressure, bone density, tumor surveillance, neuroprotection and reproduction. The endocannabinoid system has also been shown to affect sensory perception, cardiac output, cerebral blood flow and intraocular pressure.

23.01.2022 Hong Kong Just Opened its First CBD Cafe! Read more here : https://420intel.com//hong-kong-just-opened-its-first-cbd-

23.01.2022 A good resource for patients - A comparison of Australian Medical Cannabis Clinics :

23.01.2022 We have nearly 350 registered participants in our FREE Patient Webinar next Thursday! Make you sure you register NOW to make sure you don't miss out! REGISTER HERE : https://us02web.zoom.us//register/WN_9B_aNQnARxObFO2SV-_3QQ Thanks to Little Green Pharma for their support in this education! ... Also thanks to Ananda clinics and Health House Pharma for donating their time to speak and be available for all our patient questions for the Q and A panel at the end.

22.01.2022 Have you registered? Only 1 day to go till our Autism Spectrum Disorders FREE Webinar!!! Register here: https://tiny.one/fautismmcra... Help us spread the message to everyone that would be interested in this FREE Webinar #mcraorgau #mcraeducation #mcraadvocate #medicalcannabis #medicinalcannabis #cannabiseducation #freewebinarbymcra #webinareducation #endocannabioidsystem #ECS #autism #autismeducation #autismawareness #autismspectrum #autismlife #autismadvocate #littlegreenpharma #medlabclinical #zeliratheraputics

21.01.2022 Clinical Study Share : 'Emerging Promise of Cannabinoids for the Management of Pain and Associated Neuropathological Alterations in Alzheimer’s Disease' July 2020 CONCLUSION Cannabinoids act by targeting several signaling processes, such as pain, abnormal processing of A and tau, neuroinflammation, excitotoxicity, oxidative stress, and mitochondrial dysfunction, which play a pivotal role in the management of AD. Cannabinoids also ameliorate behavioral and cognitive dysfunc...tions. Therefore, due to these extensive medical uses of cannabinoid compounds, it can be said that targeting the endocannabinoid system can be a promising strategy to develop an effective therapy for the management of AD. Furthermore, cannabinoids may demonstrate a safe and reliable low-cost therapy, with limited side effects. Future research is needed to investigate the use of cannabinoids for the treatment of AD in a clinical trial setting. See more

19.01.2022 Chronic pain study announced..

19.01.2022 Sharing for Lambert Initiative for Cannabinoid Therapeutics : We are currently looking for healthy, endurance-trained runners to participate in our trial investigating the effect of oral cannabidiol (CBD) oil on exercise physiology. You may be eligible if you are:... A male, endurance-trained runner; Between 18 and 45 years old; Have not used cannabis or CBD in the last 3 months; and Willing to provide (small) blood, urine and saliva samples. Participants will need to visit the Charles Perkins Centre (Camperdown, Sydney) to complete an initial medical screen and two research sessions (approx. 5 hours each). The research sessions can be scheduled at your convenience but must begin in the morning. All participants will be reimbursed for their time. https://redcap.sydney.edu.au/surveys/?s=F3WJXNYRLP

17.01.2022 ARTICLE SHARE : Following the recent rescheduling of registered low-dosage CBD products by the Therapeutic Goods Administration (TGA) co-author Professor Iain McGregor, academic director of Sydney University's Lambert Initiative for Cannabinoid Therapeutics, has shot down the decision, suggesting it is unlikely to benefit patients. "There is no good-quality evidence that 60mg does anything useful," said Professor McGregor, calling for much higher doses to elicit the required... relief to patients suffering from chronic pain, insomnia, anxiety and epilepsy. Comparing the availability of CBD products and the associated legislative and regulatory background in nine selected countries, McGregor shows the TGA, along with many other legal authorities, have severely underestimated the required dosage for CBD products. Read more here : https://thegreenfund.com/australias-over-the-counter-cbd-is

17.01.2022 "Victoria's medicinal cannabis users could be free as early as next year to drive with the substance in their bodies as the state government considers major changes to drug-driving laws. In an Australian first, the state government could begin to treat medicinal cannabis the same as other medications as part of a plan to be drafted over coming months in consultation with MPs, police and doctors and expected to be implemented early next year." Well done Fiona Patten MP! This will set a precedent for other States to follow.

17.01.2022 Dunsborough Event Feedback https://mcra.org.au/event-feedback-dunsborough-september-2/

17.01.2022 QUESTION It has been estimated that a significant proportion of cancer patients (18.3-40.0%) in the United States use marijuana or cannabinoid-based products. Does the evidence indicate that cannabinoid-based products are effective in treating cancer-related pain? chemotherapy-induced nausea and vomiting? cancer-related cachexia (wasting)? ANSWER According to a study published in the Journal of Clinical Oncology, there is substantial evidence for the effectiveness of marijuan...a and cannabinoids in treating cancer-related pain; specifically, an oral THC/CBD spray. Also, there is conclusive evidence that marijuana and cannabinoids effectively relieve chemotherapy-induced nausea and vomiting; (specifically, oral THC). However, there is inconclusive evidence about the effectiveness of cannabinoid-based products in treating cancer-related cachexia (wasting). #mcraorgau #mcraeducation #medicalcannabis #medicinalcannabis #cannabiseducation #thc #thcresearch #cbd #cbdresearch #cancerpain #chemotherapyinducednauseaandvomiting

17.01.2022 Only just over 24hrs until our FREE patient webinar tomorrow night, so there's still time for you to register to watch. We have 464 from a possible 500 registered attendees (WOW!) so there's still room for you. Get your questions together for our panel and type them into the Q and A function on the Zoom screen.... Register here NOW : Register now at https://us02web.zoom.us//register/WN_9B_aNQnARxObFO2SV-_3QQ

16.01.2022 Clinical Study Share : 'Cannabis Improves Obsessive-Compulsive DisorderCase Report and Review of the Literature' JULY 2020 CONCLUSION There is increasing evidence that the ECS might be involved in the pathophysiology of OCD. In line with this hypothesis, from a limited number of case studies it is suggested that CBM might be effective in the treatment of OCD. However, so far it is unclear, which cannabinoidsin monotherapy of combination with other treatmentsmight be most e...ffective and which patients might respond best. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396551/

15.01.2022 Great to see the govt committing more funds to medicinal cannabis research but we'd like to see it available for research into ALL conditions, not just cancer and cancer symptoms. Broaden the scope! There are many conditions for which NO research has been done.........let's increase the condition list!

15.01.2022 We are delighted to share a recording of our first, but by no means our last, webinar for patient education. Please watch and share :)

15.01.2022 Clinical Study Share : 'CHARACTERISTICS OF MEDICAL CANNABIS USAGE AMONG PATIENTS WITH FIBROMYALGIA' - 2020 May CONCLUSIONS : MC is an effective treatment for fibromyalgia, with nearly zero % withdrawal from this treatment. C treatment enabled nearly half of the patients to discontinue any treatment for fibromyalgia and all participants recommended MC treatment for their loved ones in case they develop severe fibromyalgia. Most participants were against the reform of MC in Is...rael. Mild adverse effects were reported in nearly a quarter of the patients but did not result in discontinuing its consumption. https://pubmed.ncbi.nlm.nih.gov/32431124/

14.01.2022 Be aware, if you import your own CBD oil, you may not get what you pay for! This is really very worrying! Article - Non-targeted Screening of Commercial CBD Products in the United States Reveals Common Contamination and Adulteration, August 2020. - "Recent studies have investigated commercial CBD products using targeted assays and have found varying degrees of misrepresentation and contamination of these products."... - "We find evidence to support previous conclusions that CBD products are commonly misrepresented in terms of cannabinoid concentrations present. Specifically, we observe a wide variation in relative THC concentrations across the product tested, with some products containing 10-fold more relative signal than others. In addition, we find that several products appear to be purposely adulterated with over the counter drugs such as caffeine and melatonin. We also observe multiple small molecule contaminants that are typically linked to improper production or packaging methods in food or pharmaceutical production. Finally, we present high resolution accurate mass spectrometry data and tandem MS/MS fragments supporting the presence of trace amounts of fluorofentanyl in a single mail order CBD product." https://www.biorxiv.org/content/10.1101/2020.08.25.267302v1 See more

13.01.2022 Driving on medicinal cannabis should be considered safe An interview from Oliver Peterson's show on News Talk 6PR 882 with Dr Richard Hopkins from Zelira Therapeutics - 15/10/2020 https://www.6pr.com.au/driving-on-medicinal-cannabis-shoul/

13.01.2022 Dr Richard Kevin, a research associate from the Lambert Initiative, explains the analytical testing of cannabinoids & provides expert insight into the controver...sy around the TGA's recent audit of the #medicinal #cannabis products available in Australia. https://www.cannabiz.com.au/three-ways-we-can-make-cannabi/

13.01.2022 Great results reported from the medicinal cannabis trial for symptom relief of cancer in NSW : "Early results of a landmark trial involving 80 patients at the Chris O'Brien Lifehouse hospital show that cannabis capsules were better than placebo at improving symptoms. "An extra one in 10 people had control of nausea and vomiting, so it had improved from 14 per cent to 25 per cent," said Associate Professor Peter Grimison, a medical oncologist at Chris O'Brien Lifehouse. Read more below:

13.01.2022 Very important research, just published, regarding optimum conditions for short to long-term storage of both cannabis flower and cannabis oils. Metabolic Profiling of Cannabis Secondary Metabolites for Evaluation of Optimal Postharvest Storage Conditions - The Laboratory of Cancer Biology and Cannabinoid Research, Department of Biology, @TechnionLive... CONCLUSION "In this study we found that the best conditions for preserving the original phytocannabinoid and terpenoid contents of inflorescences throughout long storage periods are as whole inflorescences at 4C. In regards to medical Cannabis oil preparation and storage, Cannabis inflorescences intended for extraction should be stored under these optimal conditions, and then extracted as close as possible to the oil’s marketing, dissolved in olive oil, and stored at 4C. It should be noted, however, that olive oil freezes at this temperature, and so the oil should be consumed only after re-melting and proper mixing to avoid phase separation. The therapeutic use of medical Cannabis is growing, and so is the need for standardized and therapeutically stable Cannabis products for patients. Prolonged storage under sub-optimal conditions can lead to degradation or changes in biologically active phytocannabinoids and terpenoids resulting in new constituents. This can consequently alter the therapeutic effects of the Cannabis medication or lead to undesirable side effects compared with the original material. This study, therefore, provides important information that is relevant to Cannabis growers, clinicians, manufacturers, and distributors of medical Cannabis, in order to provide patients with standardized, pharmaceutical-grade Cannabis inflorescences and oils." https://www.researchgate.net//344665328_Metabolic_Profilin [accessed Oct 21 2020]

12.01.2022 RESEARCH SHARE 2020 June British Journal of Clinical Pharmacology A pilot randomised placebo-controlled trial of cannabidiol to reduce severe behavioural problems in children and adolescents with intellectual disability.... Conclusions: The findings suggest that the study protocol is feasible and acceptable to patients with ID and SBP and their families. https://pubmed.ncbi.nlm.nih.gov/32478863/

11.01.2022 Pre-Clinical Study Share : 'Roles of Cannabinoids in Melanoma: Evidence from In Vivo Studies' 21 August 2020 CONCLUSIONS: In conclusion, evidence from these in vivo studies suggest that the use of THC and CBD not only inhibited tumor growth and reduced tumor size but also seemed to improve the quality of life in animal models [31]. A synergistic approach (using two cannabinoids in combination) may be more beneficial for melanoma treatment than the use of individual cannabin...oids [32] with a potentially improved quality of life in some patients. Therefore, future in vivo studies should include both individual cannabinoid and combined cannabinoid-based approaches for the treatment of melanoma and the investigation of the mechanism underpinning the synergistic effects observed. In addition, given the large number of in vitro studies, future reviews will be needed to identify the potential underlying mechanisms of cannabinoids involved in the inhibition of melanoma and to contribute further to our understanding of the complex endocannabinoid system involvement in the treatment of cancer. See more

11.01.2022 Hi everyone. We are excited to let you know that you will be able to purchase MCRA merchandise very soon. A shop button will appear on our page and we hope to have T-shirts, mugs, caps and more available. All proceeds will go straight to our charity account to help in our fight to educate your health professionals and you all; to lobby for increased patient access and a compassionate subsidy scheme to reduce costs to this medicine for those who'd otherwise not be able to access it; and to continue to share/promote and participate in scientific research in new conditions for medicinal cannabis.

10.01.2022 We don't usually do this, but we were rather inspired by this song sent to us by Brendan Shoobert, and wanted to share it. It's called 'As Long As Its Green". In Brendan's words "It was inspired by a mate of mine suffering from MSA - Multiple System Atrophy. The medication he is on is causing a lot of side effects and the one thing that helps him deal with the side effect is Cannabis.

10.01.2022 QUESTION Does the oral administration of CBD alter plasma concentrations of diazepam? ANSWER CBD can alter the toxicity or efficacy of other drugs through inhibition of certain enzymes. For example, increases in the plasma concentration of diazepam have been reported when the diazepam is coadministered with Epidiolex (a CBD product).

08.01.2022 Another fantastic speaker lined up for our next webinar this coming Tuesday! Have you registered yet? Link in Bio Meet Dr Barbara James: ... Child & Adolescent Psychiatrist @Nest Family Clinic - Completed medical degree at the University of Melbourne 1998 - Undertook Internship and Residency initially at the Austin Hospital, and subsequently at the Alfred Hospital, in a variety of roles - Completed Psychiatric training in General Adult Psychiatry with Advanced Training in Child and Adolescent Psychiatry through the Alfred Hospital in 2007 - Joined the Adolescent Team Service at Albert Rd Clinic in 2008, and subsequently established a private practice specializing in the psychiatric care of children and adolescents. Through her work at Albert Rd Clinic, Barbara has developed a collaborative approach to the care of children and adolescents and finds liaison with and referral to other health care professionals often adds important ideas as they recover from episodes of mental illness. Individualised therapy, as well as family therapy, is often a key component of care, Barbara is experienced in providing this therapy. Please help us spread the word and share this FREE Event to everyone that wants to learn about Medical Cannabis! #mcraorgau #mcraeducation #mcraadvocate #medicalcannabis #medicinalcannabis #cannabiseducation #freewebinarbymcra #webinareducation #endocannabioidsystem #ECS #autism #autismeducation #autismawareness #autismspectrum #autismlife #autismadvocate #littlegreenpharma #medlabclinical #ZELIRA

08.01.2022 QUESTION Has cannabidiol in compounded topical pain creams been found to effectively treat pain? ANSWER According to the National Academies of Science, Engineering and Medicine’s 2020 publication, A Review of the Safety and Effectiveness of Select Ingredients in Compounded Topical Pain Creams, there is insufficient evidence on the effectiveness of topical cannabidiol to treat pain when applied to intact skin. Evidence from animal studies suggests that topically applied cannabidiol in a gel may be superior to placebo for treatment of pain, inflammation, and fibrosis.

08.01.2022 Sharing for our friends at Honahlee : The Cannabis Law Reform Alliance presents-Drive Change : A law reform campaign to amend the driving laws giving medical cannabis patients the same rights as all other patients.... Fair, effective, equal drug driving laws.

07.01.2022 MCRA relies totally on donations to survive. We have been active for over 4 years in the Australian Medicinal Cannabis space, and we receive no govt assistance in our endeavors. Help us to continue our important structured education (seminars and webinars), mission to advocate for patients and help fund upcoming clinical research by considering a donation to our PayPal Giving Fund. ANY amount is gratefully received! Thank you x

07.01.2022 Olivia Newton-John is just the perfect advocate for patient access to medicinal cannabis, in Australia and globally. What a wonderful initiative! #medicalcannabis #cannabisadvocate #medicinalcannabis #cannabiseducation #Cancer #cancerawareness #cancersurvivor

07.01.2022 QUESTION The pharmacological properties of cannabinol have been investigated. What have the studies shown? ANSWER Cannabinol (CBN) is the oxidative by-product of THC and appears after long storage. It is a weaker partial agonist at CB1 and CB2 as compared to THC. In in vitro studies, it has been found that cannabinol is anticonvulsant and anti-inflammatory, and stimulates bone formation.

07.01.2022 Yes, you can access medicinal cannabis for Austism SD for your child. AND....it has worked so well for some children. Here's proof :

07.01.2022 Curious about medicinal cannabis? Professor Iain McGregor, our academic director, and Dr Richard di Natale, outgoing Senator and former leader of the Australian... Greens, will be giving a free #webinar on the use of #medicinal #cannabis in Australia next Tuesday, 6 Oct, at 7pm. The webinar is being hosted by Musculoskeletal Australia - MSK, a support group for #arthritis, back #pain, #osteoporosis & other #musculoskeletal conditions.

06.01.2022 Another Aussie clinical trial announced. This is for #cannabidiol (#CBD) for #ChronicPain from #SpinalCordInjury run by The Lambert Initiative for Cannabinoid Therapeutics and Brain And Mind Centre If this is you, and you live in Sydney, NSW, you may be eligible to participate. https://www.sydney.edu.au//Medical-cannabis-study-spinal-i

05.01.2022 Be aware of this, for the people who toke.............New Study Reveals Over 90% Of Rolling Papers Contain Heavy Metals

05.01.2022 First cannabinoid medicine on the PBS!!! "A medicinal cannabis product designed to help Australians living with a rare form of epilepsy has become the first drug of its kind to be subsidised by the government. From Saturday, people living with Dravet syndrome will have access to Epidyolex, a new treatment used in combination with at least two other anti-epileptic medicines on the Pharmaceutical Benefits Scheme."... #mcraorgau #mcraeducation #mcraadvocate #medicalcannabis #medicinalcannabis #cannabiseducation #epilepsyawareness #epilepsy #dravetsyndrome

05.01.2022 Zelira Medicinal Cannabis Trial Enlists Retired AFL Players - Preliminary results from Zelira's trial have shown that cannabis may be able to replace morphine as a treatment option for severe chronic pain patients. Read more here : https://thegreenfund.com/zelira-medicinal-cannabis-trial-en

02.01.2022 Please help out The Lambert Initiative for Cannabinoid Therapeutics with their research :

02.01.2022 Dr. Cristina Sanchez, a biochemist with over 20 years of experience as a cannabinoid researcher, outlines the preclinical evidence of cannabinoids on different types of cancer.

02.01.2022 Meet Dr Stephen Chalk who will be presenting at our Webinar this coming Tuesday! Have you registered yet? Don't miss out! Register here: https://tiny.one/fautismmcra Dr Stephen Chalk is a GP Cannabinoid Prescriber at Key Largo Medical Centre... Stephen studied medicine at Oxford University and King’s College, London and after working in the UK moved to Joondalup Emergency Department. He relocated with his wife to Albany to complete his general practice training, gaining further experience in community palliative care, aboriginal health, paediatrics and minor surgical procedures.He also spent time in the local hospital ED and wards. His interests include men’s health, minor surgery, pain management and preventive health. He is qualified in dermoscopy and has a special interest in mole checks and early skin cancer detection. Please help us spread the word and share this FREE Event to everyone that wants to learn about Medical Cannabis! #mcraorgau #mcraeducation #mcraadvocate #medicalcannabis #medicinalcannabis #cannabiseducation #freewebinarbymcra #webinareducation #endocannabioidsystem #ECS #autism #autismeducation #autismawareness #autismspectrum #autismlife #autismadvocate #littlegreenpharma #medlabclinical #ZELIRA

01.01.2022 We KNOW full plant extracted CBD works better that CBD isolate! Here's more proof.....

01.01.2022 We are so proud to be able realise our mission to facilitate research into new conditions for which medicinal cannabis may be of benefit. Today we announced our formal fundraising commitment to help Prof. Marco Falasca continue his work in cannabinoid therapy for pancreatic cancer. He has completed considerable preclinical studies in cell lines and mouse models with encouraging results and needs to further this work and work towards readiness for patient trials. It was wonde...rful to be able to do this on World Pancreatic Cancer Day 2020! Here are links to Prof. Falasca's work - https://www.nature.com/articles/s41388-018-0390-1 https://pankind.org.au//promising-results-in-mouse-trial-/ Pancreatic Cancer is one of the deadliest cancer where the survival rate is 8-14%. It has the lowest survival rate among all major cancers. Every DAY, more than 1,257 people worldwide will be diagnosed with pancreatic cancer, and an estimated 1,184 will die from the disease. THIS IS WHY WE NEED NEW TREATMENTS AND CANNABINOIDS HOLD PROMISE! YOUR help via donations is needed to keep this research going.....We have set up a dedicated bank account for these funds, so we can make sure that money raised is easily accounted for and goes straight into his research pool. World Pancreatic Cancer Coalition #WPCD and #ItsAboutTime